GWASarchive is a service that facilitates standard annotation, documentation, quality, accessibility, and durability of GWAS results (“the data”). GWASarchive is managed by PolyKnomics BV; the company helps with data curation and provides a graphical web interface for the exploration of the data; it can also submit the data on your behalf to Zenodo’s GWASarchive community (https://zenodo.org/communities/gwasarchive/), thus ensuring data access sustainability and receiving a data DOI.

Please address your questions and request quotation at contact@gwasarchive.com, describing briefly the nature of your data (e.g. how many GWAS/traits, SNPs etc).

Trait name Trait type Study year Reference DOI N Browse
Back pain (discovery 350K)binary201810.1097/j.pain.0000000000001514350000
Back pain (meta-analysis 450K)binary201810.1097/j.pain.0000000000001514453862
Chronic back painbinary201810.1371/journal.pgen.1007601158025
Healthspanbinary201810.1038/s42003-019-0290-0300477
Ratio of fucosylated monosialylated structures with and without bisecting GlcNAc in total IgG glycansquantitative201810.1126/sciadv.aax03018090
Ratio of afucosylated digalactosylated structures with bisecting GlcNAc and all fucosylated digalactosylated structures (+/- bisecting GlcNAc) in total neutral plasma glycansquantitative201810.1101/3654862763
Ratio of afucosylated structures with bisecting GlcNAc and all fucosylated structures (+/- bisecting GlcNAc) in total neutral plasma glycansquantitative201810.1101/3654862763
Ratio of all core-fucosylated disialylated and trisialylated structures (+/- bisecting GlcNAc) in total plasma glycansquantitative201810.1101/3654862763
Ratio of all core-fucosylated monosialylated and trisialylated structures (+/- bisecting GlcNAc) in total plasma glycansquantitative201810.1101/3654862763
Ratio of all core-fucosylated sialylated structures with and without bisecting GlcNAc in total plasma glycansquantitative201810.1101/3654862763
Ratio of all fucosylated monosialylated and disialylated structures (+/- bisecting GlcNAc) in total IgG glycansquantitative201810.1126/sciadv.aax03018090
Ratio of all fucosylated monosialylated and disialylated structures (+/- bisecting GlcNAc) in total plasma glycansquantitative201810.1101/3654862763
Ratio of all fucosylated sialylated structures with and without bisecting GlcNAc in total IgG glycansquantitative201810.1126/sciadv.aax03018090
Ratio of core-fucosylated disialylated and trisialylated structures (without bisecting GlcNAc) in total plasma glycansquantitative201810.1101/3654862763
Ratio of core-fucosylated monosialylated and trisialylated structures (without bisecting GlcNAc) in total plasma glycansquantitative201810.1101/3654862763
Ratio of digalactosylated structures with bisecting GlcNAc and all fucosylated digalactosylated structures (+/- bisecting GlcNAc) in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
Ratio of disialylated and trisialylated trigalactosylated structures in total plasma glycansquantitative201810.1101/3654862763
Ratio of fucosylated monosialylated and disialylated structures (with bisecting GlcNAc) in total IgG glycansquantitative201810.1126/sciadv.aax03018090
Ratio of fucosylated digalactosylated non-bisecting GlcNAc structures and all digalactosylated structures with bisecting GlcNAc in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
Ratio of fucosylated digalactosylated non-bisecting GlcNAc structures and all digalactosylated structures with bisecting GlcNAc in total neutral plasma glycansquantitative201810.1101/3654862763
Ratio of fucosylated digalactosylated structures with and without bisecting GlcNAc in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
Ratio of fucosylated digalactosylated structures with and without bisecting GlcNAc in total neutral plasma glycansquantitative201810.1101/3654862763
Ratio of fucosylated disialylated structures with and without bisecting GlcNAc in total IgG glycansquantitative201810.1126/sciadv.aax03018090
Ratio of fucosylated disialylated structures with and without bisecting GlcNAc in total plasma glycansquantitative201810.1101/3654862763
Ratio of fucosylated monosialylated and disialylated structures (without bisecting GlcNAc) in total IgG glycansquantitative201810.1126/sciadv.aax03018090
Ratio of fucosylated monosialylated and disialylated structures (with bisecting GlcNAc) in total plasma glycansquantitative201810.1101/3654862763
Ratio of fucosylated monosialylated and disialylated structures (without bisecting GlcNAc) in total plasma glycansquantitative201810.1101/3654862763
Ratio of fucosylated monosialylated structures with and without bisecting GlcNAc in total plasma glycansquantitative201810.1101/3654862763
Ratio of fucosylated non-bisecting GlcNAc structures and all structures with bisecting GlcNAc in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
Ratio of fucosylated non-bisecting GlcNAc structures and all structures with bisecting GlcNAc in total neutral plasma glycansquantitative201810.1101/3654862763
Ratio of fucosylated structures with and without bisecting GlcNAc in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
Ratio of fucosylated structures with and without bisecting GlcNAc in total neutral plasma glycansquantitative201810.1101/3654862763
Ratio of structures with bisecting GlcNAc and all fucosylated structures (+/- bisecting GlcNAc) in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
Ratio of trisialylated and tetrasialylated tetragalactosylated structures in total plasma glycansquantitative201810.1101/3654862763
Structure not determinedquantitative201810.1126/sciadv.aax03018090
The incidence of bisecting GlcNAc in all fucosylated digalactosylated structures in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
The incidence of bisecting GlcNAc in all fucosylated digalactosylated structures in total neutral plasma glycansquantitative201810.1101/3654862763
The incidence of bisecting GlcNAc in all fucosylated disialylated structures in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The incidence of bisecting GlcNAc in all fucosylated disialylated structures in total plasma glycansquantitative201810.1101/3654862763
The incidence of bisecting GlcNAc in all fucosylated monosialylated structures in total IgG glycans in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The incidence of bisecting GlcNAc in all fucosylated monosialylated structures in total plasma glycansquantitative201810.1101/3654862763
The incidence of bisecting GlcNAc in all fucosylated structures in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
The incidence of bisecting GlcNAc in all fucosylated structures in total neutral plasma glycansquantitative201810.1101/3654862763
The percentage of A2 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of A2 glycan in total neutral IgG glycans (GPn)quantitative201810.1126/sciadv.aax03018090
The percentage of A2BG2 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of A2BG2 glycan in total neutral IgG glycans (GPn)quantitative201810.1126/sciadv.aax03018090
The percentage of A2BG2 in total neutral plasma glycans (GPn)quantitative201810.1101/3654862763
The percentage of A2BG2 in total plasma glycansquantitative201810.1101/3654862763
The percentage of A2BG2S2 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of A2G1 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of A2G1 glycan in total neutral IgG glycans (GPn)quantitative201810.1126/sciadv.aax03018090
The percentage of A2G2 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of A2G2 glycan in total neutral IgG glycans (GPn)quantitative201810.1126/sciadv.aax03018090
The percentage of A2G2 in total neutral plasma glycans (GPn)quantitative201810.1101/3654862763
The percentage of A2G2 in total plasma glycansquantitative201810.1101/3654862763
The percentage of A2G2S1 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of A2G2S2 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of A2G2S[3,6]2 + A2G2S[3,3]2 in total plasma glycansquantitative201810.1101/3654862763
The percentage of A2G2S[3,6]2 + A2G2S[6,6]2 + A2G2S[3,3]2 in total plasma glycansquantitative201810.1101/3654862763
The percentage of A2G2S[6]1 + A2G2S[3]1 in total plasma glycansquantitative201810.1101/3654862763
The percentage of A2[3]BG1S[3]1 + A2[3]BG1S[6]1 in total plasma glycansquantitative201810.1101/3654862763
The percentage of A2[6]BG1 in total neutral plasma glycans (GPn)quantitative201810.1101/3654862763
The percentage of A2[6]BG1 in total plasma glycansquantitative201810.1101/3654862763
The percentage of A3F1G3S[3,3,3]3 + A3F1G3S[3,3,6]3in total plasma glycansquantitative201810.1101/3654862763
The percentage of A3G3S[3,3,3]3 in total plasma glycansquantitative201810.1101/3654862763
The percentage of A3G3S[3,3,6]3 + A3G3S[3,6,6]3 in total plasma glycansquantitative201810.1101/3654862763
The percentage of A3G3S[3,3,6]3 in total plasma glycansquantitative201810.1101/3654862763
The percentage of A3G3S[3,3]2 in total plasma glycansquantitative201810.1101/3654862763
The percentage of A3G3S[3,6]2 in total plasma glycansquantitative201810.1101/3654862763
The percentage of A4F1G3S[3,3,3]3 + A4F1G3S[3,3,6]3 + A4F1G3S[3,6,6]3 in total plasma glycansquantitative201810.1101/3654862763
The percentage of A4F1G4S[3,3,3,6]4 in total plasma glycansquantitative201810.1101/3654862763
The percentage of A4G4S[3,3,3,3]4 in total plasma glycansquantitative201810.1101/3654862763
The percentage of A4G4S[3,3,3,6]4 in total plasma glycansquantitative201810.1101/3654862763
The percentage of A4G4S[3,3,3]3 in total plasma glycansquantitative201810.1101/3654862763
The percentage of A4G4S[3,3,6]3 + A4G4S[3,6,6]3 in total plasma glycansquantitative201810.1101/3654862763
The percentage of A4G4S[3,6,6,6]4 in total plasma glycansquantitative201810.1101/3654862763
The percentage of FA1 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of FA1 glycan in total neutral IgG glycans (GPn)quantitative201810.1126/sciadv.aax03018090
The percentage of FA2 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of FA2 glycan in total neutral IgG glycans (GPn)quantitative201810.1126/sciadv.aax03018090
The percentage of FA2 in total neutral plasma glycans (GPn)quantitative201810.1101/3654862763
The percentage of FA2 in total plasma glycansquantitative201810.1101/3654862763
The percentage of FA2B glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of FA2B glycan in total neutral IgG glycans (GPn)quantitative201810.1126/sciadv.aax03018090
The percentage of FA2BG2 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of FA2BG2 glycan in total neutral IgG glycans (GPn)quantitative201810.1126/sciadv.aax03018090
The percentage of FA2BG2 in total neutral plasma glycans (GPn)quantitative201810.1101/3654862763
The percentage of FA2BG2 in total plasma glycansquantitative201810.1101/3654862763
The percentage of FA2BG2S1 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of FA2BG2S2 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of FA2BG2S[3,6]2 + FA2BG2S[6,6]2 + FA2BG2S[3,3]2 in total plasma glycansquantitative201810.1101/3654862763
The percentage of FA2BG2S[3]1 + FA2BG2S[3]1 in total plasma glycansquantitative201810.1101/3654862763
The percentage of FA2G1S1 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of FA2G2 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of FA2G2 glycan in total neutral IgG glycans (GPn)quantitative201810.1126/sciadv.aax03018090
The percentage of FA2G2 in total neutral plasma glycans (GPn)quantitative201810.1101/3654862763
The percentage of FA2G2 in total plasma glycansquantitative201810.1101/3654862763
The percentage of FA2G2S1 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of FA2G2S2 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of FA2G2S[3,6]2 + FA2G2S[3,3]2 + FA2G2S[6,6]2 in total plasma glycansquantitative201810.1101/3654862763
The percentage of FA2G2S[6]1 + FA2G2S[3]1 in total plasma glycansquantitative201810.1101/3654862763
The percentage of FA2[3]BG1 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of FA2[3]BG1 glycan in total neutral IgG glycans (GPn)quantitative201810.1126/sciadv.aax03018090
The percentage of FA2[3]G1 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of FA2[3]G1 glycan in total neutral IgG glycans (GPn)quantitative201810.1126/sciadv.aax03018090
The percentage of FA2[3]G1 in total neutral plasma glycans (GPn)quantitative201810.1101/3654862763
The percentage of FA2[3]G1 in total plasma glycansquantitative201810.1101/3654862763
The percentage of FA2[3]G1S[3]1 + FA2[3]G1S[6]1 in total plasma glycansquantitative201810.1101/3654862763
The percentage of FA2[6]BG1 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of FA2[6]BG1 glycan in total neutral IgG glycans (GPn)quantitative201810.1126/sciadv.aax03018090
The percentage of FA2[6]BG1 in total neutral plasma glycans (GPn)quantitative201810.1101/3654862763
The percentage of FA2[6]BG1 in total plasma glycansquantitative201810.1101/3654862763
The percentage of FA2[6]G1 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of FA2[6]G1 glycan in total neutral IgG glycans (GPn)quantitative201810.1126/sciadv.aax03018090
The percentage of FA2[6]G1 in total neutral plasma glycans (GPn)quantitative201810.1101/3654862763
The percentage of FA2[6]G1 in total plasma glycansquantitative201810.1101/3654862763
The percentage of FA3G3S[3,3,3]3 in total plasma glycansquantitative201810.1101/3654862763
The percentage of FA3G3S[3,3,6]3 + FA3G3S[3,6,6]3 in total plasma glycansquantitative201810.1101/3654862763
The percentage of M5 + FA2B in total neutral plasma glycans (GPn)quantitative201810.1101/3654862763
The percentage of M5 + FA2B in total plasma glycansquantitative201810.1101/3654862763
The percentage of M5 glycan in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of M5 glycan in total neutral IgG glycans (GPn)quantitative201810.1126/sciadv.aax03018090
The percentage of M6 D3 in total neutral plasma glycans (GPn)quantitative201810.1101/3654862763
The percentage of M6 D3 in total plasma glycansquantitative201810.1101/3654862763
The percentage of M9 in total neutral plasma glycans (GPn)quantitative201810.1101/3654862763
The percentage of M9 in total plasma glycansquantitative201810.1101/3654862763
The percentage of agalactosylated structures in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of agalactosylated structures in total neutral plasma glycansquantitative201810.1101/3654862763
The percentage of agalactosylated structures in total plasma glycansquantitative201810.1101/3654862763
The percentage of all fucosylated structures (+/- bisecting GlcNAc) in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of all fucosylated structures (+/- bisecting GlcNAc) in total neutral plasma glycansquantitative201810.1101/3654862763
The percentage of antennary fucosylated structures in total plasma glycomequantitative201810.1101/3654862763
The percentage of antennary-fucosylation of tetragalactosylated structures in total plasma glycansquantitative201810.1101/3654862763
The percentage of antennary-fucosylation of trigalactosylated structures in total plasma glycansquantitative201810.1101/3654862763
The percentage of biantennary structures in total plasma glycansquantitative201810.1101/3654862763
The percentage of bisyalated structures in total plasma glycomequantitative201810.1101/3654862763
The percentage of core fucosylated structures in total plasma glycomequantitative201810.1101/3654862763
The percentage of core-fucosylation of trigalactosylated structures in total plasma glycansquantitative201810.1101/3654862763
The percentage of digalactosylated structures in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of digalactosylated structures in total neutral plasma glycansquantitative201810.1101/3654862763
The percentage of digalactosylated structures in total plasma glycansquantitative201810.1101/3654862763
The percentage of disialylation of core-fucosylated digalactosylated structures with bisecting GlcNAc in total plasma glycansquantitative201810.1101/3654862763
The percentage of disialylation of core-fucosylated digalactosylated structures without bisecting GlcNAc in total plasma glycansquantitative201810.1101/3654862763
The percentage of disialylation of fucosylated digalactosylated structures with bisecting GlcNAc in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of disialylation of fucosylated digalactosylated structures without bisecting GlcNAc in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of fucosylated structures (without bisecting GlcNAc) in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of fucosylated structures (with bisecting GlcNAc) in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycansquantitative201810.1101/3654862763
The percentage of fucosylated structures (without bisecting GlcNAc) in total neutral plasma glycansquantitative201810.1101/3654862763
The percentage of fucosylation of agalactosylated structures (with bisecting GlcNAc) in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of fucosylation of agalactosylated structures (with bisecting GlcNAc) in total neutral plasma glycansquantitative201810.1101/3654862763
The percentage of fucosylation of agalactosylated structures (without bisecting GlcNAc) in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of fucosylation of agalactosylated structures (without bisecting GlcNAc) in total neutral plasma glycansquantitative201810.1101/3654862763
The percentage of fucosylation of agalactosylated structures in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of fucosylation of digalactosylated structures (with bisecting GlcNAc) in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of fucosylation of digalactosylated structures (with bisecting GlcNAc) in total neutral plasma glycansquantitative201810.1101/3654862763
The percentage of fucosylation of digalactosylated structures (without bisecting GlcNAc) in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of fucosylation of digalactosylated structures (without bisecting GlcNAc) in total neutral plasma glycansquantitative201810.1101/3654862763
The percentage of fucosylation of digalactosylated structures in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of fucosylation of digalactosylated structures in total neutral plasma glycansquantitative201810.1101/3654862763
The percentage of fucosylation of monogalactosylated structures (with bisecting GlcNAc) in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of fucosylation of monogalactosylated structures (with bisecting GlcNAc) in total neutral plasma glycansquantitative201810.1101/3654862763
The percentage of fucosylation of monogalactosylated structures (without bisecting GlcNAc) in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of fucosylation of monogalactosylated structures (without bisecting GlcNAc) in total neutral plasma glycansquantitative201810.1101/3654862763
The percentage of fucosylation of monogalactosylated structures in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of fucosylation of monogalactosylated structures in total neutral plasma glycansquantitative201810.1101/3654862763
The percentage of glycan structures with bisecting GlcNAc in total plasma glycansquantitative201810.1101/3654862763
The percentage of high-mannose structures in total plasma glycansquantitative201810.1101/3654862763
The percentage of monogalactosylated structures in total neutral IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of monogalactosylated structures in total neutral plasma glycansquantitative201810.1101/3654862763
The percentage of monogalactosylated structures in total plasma glycansquantitative201810.1101/3654862763
The percentage of monosialylation of core-fucosylated digalactosylated structures with bisecting GlcNAc in total plasma glycansquantitative201810.1101/3654862763
The percentage of monosialylation of core-fucosylated digalactosylated structures without bisecting GlcNAc in total plasma glycansquantitative201810.1101/3654862763
The percentage of monosialylation of core-fucosylated monogalactosylated structures without bisecting GlcNAc in total plasma glycansquantitative201810.1101/3654862763
The percentage of monosialylation of fucosylated digalactosylated structures with bisecting GlcNAc in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of monosialylation of fucosylated digalactosylated structures without bisecting GlcNAc in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of monosialylation of fucosylated monogalactosylated structures without bisecting GlcNAc in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of monosyalated structures in total plasma glycomequantitative201810.1101/3654862763
The percentage of neutral glycan structures in total plasma glycomequantitative201810.1101/3654862763
The percentage of sialylation of all core-fucosylated structures with bisecting GlcNAc in total plasma glycansquantitative201810.1101/3654862763
The percentage of sialylation of all core-fucosylated structures without bisecting GlcNAc in total plasma glycansquantitative201810.1101/3654862763
The percentage of sialylation of all fucosylated structures with bisecting GlcNAc in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of sialylation of all fucosylated structures without bisecting GlcNAc in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of sialylation of core-fucosylated galactosylated structures with bisecting GlcNAc in total plasma glycansquantitative201810.1101/3654862763
The percentage of sialylation of core-fucosylated galactosylated structures without bisecting GlcNAc in total plasma glycansquantitative201810.1101/3654862763
The percentage of sialylation of fucosylated galactosylated structures with bisecting GlcNAc in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of sialylation of fucosylated galactosylated structures without bisecting GlcNAc in total IgG glycansquantitative201810.1126/sciadv.aax03018090
The percentage of tetraantenary structures in total plasma glycansquantitative201810.1101/3654862763
The percentage of tetragalactosylated structures in total plasma glycansquantitative201810.1101/3654862763
The percentage of tetrasyalated structures in total plasma glycomequantitative201810.1101/3654862763
The percentage of trigalactosylated structures in total plasma glycansquantitative201810.1101/3654862763
The percentage of triiantennary structures in total plasma glycansquantitative201810.1101/3654862763
The percentage of trisyalated structures in total plasma glycomequantitative201810.1101/3654862763
, GWAS ID: